podofilox derivatives (PharmaMar)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namepodofilox derivatives (PharmaMar)
Drug Alias Namepodophyllotoxin derivatives (PharmaMar)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsRejection of organ transplantationGraft vs Host DiseaseColonic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharma Mar Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb CompanyPharma Mar Sa
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationGraft vs Host DiseaseColonic Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A